Readability test, Focus Test and Bridging Report
The European and Italian regulations on drugs provides for that medicinal products entering the Italian market are accompanied by a...
The European and Italian regulations on drugs provides for that medicinal products entering the Italian market are accompanied by a...
The US Food and Drug Administration (FDA) has published a long-waited proposal to harmonise the quality system of medical devices...
Following the publication of the regulation of veterinary medicines (EU) 2019/6, EMA has decided to implement the information regarding veterinary...
The compliance with the provisions of the Biocide Regulation has proved to be hard and expensive even for big multinationals....
Italy has always been characterised by high inventive and productivity, that often make unique the discoveries and/or inventions of our...
The progressive economic recovery of China following the peak of health emergency related to Covid-19 is a good sign. More and more...
Let’s face it, the introduction of a European directive on biocides has greatly confused and frightened the many interesting industries...
How can we be sure that a common disinfectant is really effective against bacteria and harmful organisms? And the doubt...
The database for medical devices of the Italian Ministry of Health has been object of important updates these days: indeed starting from...
Il Sole 24 Ore – November 22, 2021 –Di Renzo Regulatory Affairs, a future-oriented company committed to change With 40 years...
Headquarter
Legal Office
Sede di Milano
© 2021 Di Renzo® s.r.l.
Sede legale: Viale Manzoni 59 – 00185 Roma
Sede operativa: Via dell’Arco di Travertino 11 – 00178 Roma
+39 0677209020 - P. Iva 07227271009 - Cookies Policy - Trattamento dei dati
© Copyright 2025 Di Renzo Regulatory Affairs. All Rights Reserved by Di Renzo Regulatory Affairs